Back
Capricor Therapeutics Stock Price Chart
Crowdfunding to IPO: Nasdaq's Next Breakout?
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
21
CAPR
Capricor Therapeutics
Last Price:
$9.23
Seasonality Move:
-8.49%
7 Day Trial
ALL ACCESS PASS
$
7
Apple's Drop in iPhone Sales Opens the Door for New Entrant
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CAPR is experiencing slight buying pressure.
Capricor Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 11.49 | Sell |
| 20-day SMA: | 12.33 | Sell |
| 50-day SMA: | 13.72 | Sell |
| 200-day SMA: | 11.54 | Sell |
| 8-day EMA: | 10.99 | Sell |
| 20-day EMA: | 12.17 | Sell |
| 50-day EMA: | 13.28 | Sell |
| 200-day EMA: | 12.01 | Sell |
Capricor Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.99 | Sell |
| Relative Strength Index (14 RSI): | 34.91 | Sell |
| Chaikin Money Flow: | 588103 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (11.27 - 14.19) | Sell |
| Bollinger Bands (100): | (12.49 - 17.07) | Sell |
Capricor Therapeutics Technical Analysis
| Mar 20 | Mar 21 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 28 | Mar 31 | Apr 1 | Apr 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | Apr | |||||||||
| 20 | 21 | 24 | 25 | 26 | 27 | 28 | 31 | 01 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Capricor Therapeutics Stock
Is Capricor Therapeutics Stock a Buy?
-
Capricor Therapeutics share price is 9.74 while CAPR 8-day simple moving average is 11.49, which is a Sell signal.
-
The stock price of CAPR is 9.74 while Capricor Therapeutics 20-day SMA is 12.33, which makes it a Sell.
-
Capricor Therapeutics 50-day simple moving average is 13.72 while CAPR share price is 9.74, making it a Sell technically.
-
CAPR stock price is 9.74 and Capricor Therapeutics 200-day simple moving average is 11.54, creating a Sell signal.
CAPR Technical Analysis vs Fundamental Analysis
Sell
21
Capricor Therapeutics (CAPR)
is a Sell
Is Capricor Therapeutics a Buy or a Sell?
-
Capricor Therapeutics stock is rated a SellThe current Capricor Therapeutics [CAPR] share price is $9.74. The Score for CAPR is 21, which is 58% below its historic median score of 50, and infers higher risk than normal.
Capricor Therapeutics Stock Info
Market Cap:
444.9M
Price in USD:
9.74
Share Volume:
1.2M
Capricor Therapeutics 52-Week Range
52-Week High:
23.40
52-Week Low:
3.52
Sell
21
Capricor Therapeutics (CAPR)
is a Sell
Capricor Therapeutics Share Price Forecast
-
What is the Capricor Therapeutics stock price today?The Capricor Therapeutics stock price is 9.74 USD today.
-
Will CAPR stock go up or go down?Capricor Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Capricor Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Capricor Therapeutics is overvalued.
Is Capricor Therapeutics Stock a Buy?
-
Capricor Therapeutics share price is 9.74 while CAPR 8-day exponential moving average is 10.99, which is a Sell signal.
-
The stock price of CAPR is 9.74 while Capricor Therapeutics 20-day EMA is 12.17, which makes it a Sell.
-
Capricor Therapeutics 50-day exponential moving average is 13.28 while CAPR share price is 9.74, making it a Sell technically.
-
CAPR stock price is 9.74 and Capricor Therapeutics 200-day simple moving average is 12.01, creating a Sell signal.
Fundamental Analysis of Capricor Therapeutics
Is Capricor Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $0.62 per share, a decrease next quarter of $0.65 per share, an increase this year of $0.82 per share, and an increase next year of $0.18 per share.
Technical Analysis of Capricor Therapeutics
Should I short Capricor Therapeutics stock?
-
CAPR Moving Average Covergence Divergence (MACD) indicator is -0.99, suggesting Capricor Therapeutics is a Sell
-
Capricor Therapeutics Relative Strength Index (RSI) is 34.91, which suggest Capricor Therapeutics is oversold
-
The Bollinger Bands (25) for Capricor Therapeutics is (11.27 - 14.19), which suggest Capricor Therapeutics is a Sell
-
The Bollinger Bands (100) for Capricor Therapeutics is (12.49 - 17.07), which suggest Capricor Therapeutics is a Sell
* Capricor Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.